Funding for COVID-19 vaccines, testing, and healthcare support
This Act appropriates funds for the fiscal year 2021 to combat the COVID-19 pandemic. The funds are designated to support vaccine distribution, expand testing and contact tracing capabilities, and provide financial relief to healthcare providers. It also includes funding for vaccine research, the Strategic National Stockpile, and mental health and substance abuse services.
Key points
$8.5 billion for planning, distributing, and monitoring COVID-19 vaccines, including establishing vaccination centers.
$50 billion for testing, contact tracing, surveillance, and mitigation strategies.
$35 billion for the Provider Relief Fund to reimburse eligible healthcare providers for expenses or lost revenues attributable to coronavirus.
$3.5 billion total for block grants regarding community mental health services and substance abuse prevention and treatment.
Expired
Additional Information
Print number: 117_HR_1371
Sponsor: Rep. Reed, Tom [R-NY-23]
Process start date: 2021-02-25